Valuation: Prenetics Global Limited

Market Cap 37Cr 32Cr 30Cr 28Cr 52Cr 3.55TCr 53Cr 358.28Cr 139.92Cr 1.73TCr 138.08Cr 135.11Cr 6.03TCr P/E 2026 *
-7.45x
P/E 2027 * -76x
Enterprise Value 37Cr 32Cr 30Cr 28Cr 52Cr 3.55TCr 53Cr 358.28Cr 139.92Cr 1.73TCr 138.08Cr 135.11Cr 6.03TCr EV / Sales 2026 *
1.7x
EV / Sales 2027 * 0.97x
Free-Float
85.05%
Yield 2026 *
-
Yield 2027 * -
1 day-11.16%
1 week-0.82%
Current month+1.57%
1 month-2.71%
3 months+8.13%
6 months+2.75%
Current year+23.30%
1 week 17.18
Extreme 17.18
22.75
1 month 15.91
Extreme 15.91
22.75
Current year 14
Extreme 14
23.63
1 year 7.18
Extreme 7.175
23.63
3 years 2.85
Extreme 2.85
23.63
5 years 2.85
Extreme 2.85
131.25
10 years 2.85
Extreme 2.85
131.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 52 01/01/2014
Chief Executive Officer 47 01/01/2014
Director of Finance/CFO 41 01/01/2018
Director TitleAgeSince
Director/Board Member 60 13/06/2024
Chairman 47 01/01/2014
Director/Board Member - 16/02/2026
Date Insider Type Main position Quantity % Market Cap.
10/07/26 Other

CFO of IM8 (US) LLC

56,851 0.3729%
04/07/26 Fiscal year

Director

4,000 0.0262%
15/06/26 Fiscal year

Director

15,625 0.1025%
Change 5-day change 1-year change 3-year change Capi.($)
-11.16%-0.82%+139.16%+59.84% 37Cr
+0.18%+12.86%-19.87%-11.85% 18TCr
+0.15%+1.91%-10.52%-7.81% 10TCr
+1.49%+2.86%+4.13%+58.40% 5.85TCr
-0.82%-1.93%+38.23%+58.17% 5.14TCr
-0.12%-1.23%-15.62%-42.24% 4.22TCr
+1.21%-4.59% - - 3.14TCr
-1.33%-3.09%-17.20%-46.03% 2.76TCr
-0.82%-0.98%+62.39%-5.79% 2.53TCr
+0.03%-0.39%-5.83%-9.24% 2.05TCr
Average -1.12%+1.71%+19.43%+5.94% 5.37TCr
Weighted average by Cap. +0.12%+3.98%-3.95%+0.28%

Financials

2026 *2027 *
Net sales 22Cr 19Cr 18Cr 16Cr 30Cr 2.09TCr 31Cr 210.39Cr 82Cr 1.02TCr 81Cr 79Cr 3.54TCr 38Cr 33Cr 31Cr 28Cr 53Cr 3.65TCr 54Cr 367.69Cr 143.6Cr 1.78TCr 141.71Cr 138.67Cr 6.18TCr
Net income -6.94Cr -6.1Cr -5.67Cr -5.22Cr -9.78Cr -670.61Cr -9.97Cr -68Cr -26Cr -327.48Cr -26Cr -26Cr -1.14TCr -56.7L -49.85L -46.28L -42.59L -79.85L -55Cr -81.39L -5.52Cr -2.16Cr -27Cr -2.13Cr -2.08Cr -93Cr
Net Debt - -
Logo Prenetics Global Limited
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Employees
98
Date Price Change Volume
23/26/23 $19.42 -11.16% 2,58,929
22/26/22 $21.86 -0.88% 3,10,642
21/26/21 $22.06 +5.88% 4,37,474
20/26/20 $20.83 +13.89% 2,91,812
17/26/17 $18.29 -3.28% 1,34,131
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
21.86USD
Average target price
34.20USD
Spread / Average Target
+56.45%

Quarterly revenue - Rate of surprise